Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8(+) T cells through reduction of tumor-associated macrophage and activation of the interferon pathway

por Kato, Yu, Tabata, Kimiyo, Kimura, Takayuki, Yachie-Kinoshita, Ayako, Ozawa, Yoichi, Yamada, Kazuhiko, Ito, Junichi, Tachino, Sho, Hori, Yusaku, Matsuki, Masahiro, Matsuoka, Yukiko, Ghosh, Samik, Kitano, Hiroaki, Nomoto, Kenichi, Matsui, Junji, Funahashi, Yasuhiro
Publicado 2019